ERRβ: Validating a novel target for triple-negative breast cancer

被引：0
|
作者：
Fernandez, Aileen I. [1 ]
Graham, Garrett [1 ]
Gyorffy, Balazs [2 ]
Cavalli, Luciane R. [1 ]
Riggins, Rebecca B. [1 ]
机构：
[1] Georgetown Univ, Washington, DC USA
[2] Semmelweis Univ, Budapest, Hungary
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2020年 / 29卷 / 06期
关键词：
D O I：
10.1158/1538-7755.DISP18-C103
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C103
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Triple-negative breast cancer
    Reinaldo D Chacón
    María V Costanzo
    Breast Cancer Research, 12
  • [32] Triple-negative breast cancer
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2020, 120 (08) : 22 - 23
  • [33] cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?
    Gaule, Patricia B.
    Crown, John
    O'Donovan, Norma
    Duffy, Michael J.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (09) : 999 - 1009
  • [34] CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
    Meiou Dai
    Chenjing Zhang
    Ayad Ali
    Xinyuan Hong
    Jun Tian
    Chieh Lo
    Nadège Fils-Aimé
    Sergio A. Burgos
    Suhad Ali
    Jean-Jacques Lebrun
    Scientific Reports, 6
  • [35] DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
    Kurani, Hetakshi
    Razavipour, Seyedeh Fatemeh
    Harikumar, Kuzhuvelil B.
    Dunworth, Matthew
    Ewald, Andrew J.
    Nasir, Apsra
    Pearson, Gray
    Van Booven, Derek
    Zhou, Zhiqun
    Azzam, Diana
    Wahlestedt, Claes
    Slingerland, Joyce
    CLINICAL CANCER RESEARCH, 2022, 28 (09) : 1948 - 1965
  • [36] CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
    Dai, Meiou
    Zhang, Chenjing
    Ali, Ayad
    Hong, Xinyuan
    Tian, Jun
    Lo, Chieh
    Fils-Aime, Nadege
    Burgos, Sergio A.
    Ali, Suhad
    Lebrun, Jean-Jacques
    SCIENTIFIC REPORTS, 2016, 6
  • [37] ZBTB7A is a tumor suppressor and novel therapeutic target in triple-negative breast cancer
    Molloy, Mary Ellen
    Lewinska, Monika
    Liu, Xue-Song
    Wang, Angela A.
    Yuan, Zhi-Min
    CANCER RESEARCH, 2016, 76
  • [38] PIM1, a novel target in chemotherapy-resistant triple-negative breast cancer
    Braso-Maristany, Fara
    Filosto, Simone
    Catchpole, Steven
    Marlow, Rebecca
    Quist, Jelmar
    Domenech, Erika Francesch
    Liccardi, Gianmaria
    Zakka, Leila
    Serra, Violeta
    Gris, Albert
    Cheang, Maggie
    Patel, Nirmesh
    Rosell, Anna Perdrix
    Gazinska, Patrycja
    Noel, Elodie
    Watkins, Jonathan
    Marra, Pierfrancesco
    Grigoriadis, Anita
    Tutt, Andrew
    CANCER RESEARCH, 2016, 76
  • [39] Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?
    Synnott, N. C.
    Murray, A.
    McGowan, P. M.
    Kiely, M.
    Kiely, P. A.
    O'Donovan, N.
    O'Connor, D. P.
    Gallagher, W. M.
    Crown, J.
    Duffy, M. J.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (01) : 234 - 246
  • [40] Triple-Negative Breast Cancer: Not Entirely Negative
    Leone, Jose Pablo
    Puhalla, Shannon
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 856 - +
12345